4.6 Article

Antibodies enhance the infection of phorbol-ester-differentiated human monocyte-like cells with coxsackievirus B4

Journal

MICROBES AND INFECTION
Volume 15, Issue 1, Pages 18-27

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.micinf.2012.10.005

Keywords

THP-1; Monocyte; Coxsacicievirus B4; Alpha interferon; infection

Funding

  1. Ministere de l'Education Nationale de la Recherche et de la Technologie, Universite Lille 2 (UPRES) [EA3610]
  2. CHRU Lille
  3. Nord-Pasde-Calais Region
  4. EU [LSHB-CT-2003-503410, GA-261441-PEVNET]

Ask authors/readers for more resources

Coxsackievirus B4 (CV-B4), in presence of antibodies and through a specific viral receptor CAR and Fc gamma receptors II and III, can infect monocytes which results in interferon-alpha synthesis. The antibody-dependent enhancement of CV-B4 infection in the human monocytic-like THP-1 cell line has been investigated. The preincubation of CV-B4 with human plasma or human polyvalent immunoglobulins enhanced the infection of phorbol-myristate-acetate (PMA)-activated THP-1 cell cultures. CV-B4 replicated in these cells as demonstrated by the intracellular detection of infectious particles, viral protein VP1 (immunofluorescence), positive and negative viral RNA (RT-PCR). The viability of infected and control cell cultures was not different up to 20 days post-infection. Activated cell cultures inoculated with CV-B4 harbored intracellular RNA up to 14 days post-infection and produced IFN alpha that was detected by intracellular immunofluorescence staining as soon as 4 h post-infection with a maximum at 48 h post-infection and by RT-PCR all along the experiment. Together, these data demonstrate that PMA-activated THP-1 cells can be infected with CV-B4, can produce IFN alpha as a result of interactions between the virus, antibodies and specific receptors. This cellular model can be used to investigate further the mechanism and the result of the antibody-dependent enhancement of CV-B4 infection. (C) 2012 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available